Bivalirudin Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-562

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bivalirudin (NDC 63323-562). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Biv07 0000 01

FDA Label Image

Biv07 0000 02

FDA Label Image

Biv07 0000 03

Biv07 0000 03
This is a medication label for Bivalirudin, which is used for intravenous purposes only. The medication is meant for single use only and should be administered by a healthcare professional. The label includes the drug code and some branding information for "PREMIERProRx".*
FDA Label Image

Biv07 0000 04

Biv07 0000 04
Bivalirudin for Injection is a medication provided in 10 single-dose vials, with 250mg per vial. It is meant for intravenous use only, and any unused portion must be disposed of. The manufacturer is PREMIERPrORX®, and the National Drug Code (NDC) for the medication is 63323-562-15.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.